News
Alivus Life Sciences standalone net profit rises 36.41% in the September 2025 quarter
07-Nov-2025 | 07:41
Sales rise 16.00% to Rs 587.98 crore
Net profit of Alivus Life Sciences rose 36.41% to Rs 130.03 crore in the quarter ended September 2025 as against Rs 95.32 crore during the previous quarter ended September 2024. Sales rose 16.00% to Rs 587.98 crore in the quarter ended September 2025 as against Rs 506.88 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended | ||
| Sep. 2025 | Sep. 2024 | % Var. | |
| Sales | 587.98 | 506.88 | 16 |
| OPM % | 30.47 | 26.51 | - |
| PBDT | 192.58 | 142.55 | 35 |
| PBT | 174.14 | 127.46 | 37 |
| NP | 130.03 | 95.32 | 36 |
Powered by Capital Market - Live News